akzo nobel nv - AKZOY

AKZOY

Close Chg Chg %
19.42 -0.05 -0.26%

Closed Market

19.37

-0.05 (0.26%)

Volume: 107.53K

Last Updated:

Nov 22, 2024, 3:53 PM EDT

Company Overview: akzo nobel nv - AKZOY

AKZOY Key Data

Open

$19.42

Day Range

19.21 - 19.50

52 Week Range

19.21 - 27.99

Market Cap

$9.99B

Shares Outstanding

512.33M

Public Float

512.32M

Beta

1.26

Rev. Per Employee

N/A

P/E Ratio

16.36

EPS

$1.19

Yield

289.15%

Dividend

$0.11

EX-DIVIDEND DATE

Nov 7, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

124.87K

 

AKZOY Performance

1 Week
 
-0.51%
 
1 Month
 
-8.70%
 
3 Months
 
-7.74%
 
1 Year
 
-23.33%
 
5 Years
 
-39.27%
 

AKZOY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 18
Full Ratings ➔

About akzo nobel nv - AKZOY

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

AKZOY At a Glance

Akzo Nobel NV
Christian Neefestraat 2
Amsterdam, Noord-Holland 1070 AS
Phone 31-20-502-75-55 Revenue 11.53B
Industry Industrial Specialties Net Income 477.85M
Sector Process Industries 2023 Sales Growth 1.18%
Fiscal Year-end 12 / 2024 Employees 35,200
View SEC Filings

AKZOY Valuation

P/E Current 16.356
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 29.503
Price to Sales Ratio 1.228
Price to Book Ratio 2.953
Price to Cash Flow Ratio 10.825
Enterprise Value to EBITDA 12.024
Enterprise Value to Sales 1.612
Total Debt to Enterprise Value 0.331

AKZOY Efficiency

Revenue/Employee 327,651.74
Income Per Employee 13,575.372
Receivables Turnover 4.05
Total Asset Turnover 0.708

AKZOY Liquidity

Current Ratio 1.059
Quick Ratio 0.77
Cash Ratio 0.312

AKZOY Profitability

Gross Margin 37.777
Operating Margin 10.077
Pretax Margin 7.096
Net Margin 4.143
Return on Assets 2.968
Return on Equity 10.284
Return on Total Capital 4.426
Return on Invested Capital 5.875

AKZOY Capital Structure

Total Debt to Total Equity 128.714
Total Debt to Total Capital 56.277
Total Debt to Total Assets 37.326
Long-Term Debt to Equity 73.23
Long-Term Debt to Total Capital 32.018
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Akzo Nobel Nv - AKZOY

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
9.72B 11.33B 11.40B 11.53B
Sales Growth
-6.34% +16.53% +0.59% +1.18%
Cost of Goods Sold (COGS) incl D&A
5.64B 6.87B 7.50B 7.18B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
414.95M 414.88M 380.45M 383.80M
Depreciation
341.99M 332.14M 289.02M 297.31M
Amortization of Intangibles
72.96M 82.74M 91.43M 86.49M
COGS Growth
-8.70% +21.79% +9.09% -4.26%
Gross Income
4.08B 4.46B 3.90B 4.36B
Gross Income Growth
-2.87% +9.27% -12.50% +11.62%
Gross Profit Margin
+41.98% +39.37% +34.24% +37.78%
2020 2021 2022 2023 5-year trend
SG&A Expense
2.98B 3.22B 3.06B 3.19B
Research & Development
250.79M 251.76M 253.28M 271.36M
Other SG&A
2.73B 2.97B 2.81B 2.92B
SGA Growth
-8.41% +7.93% -4.94% +4.42%
Other Operating Expense
- - - -
-
Unusual Expense
- - 93.54M 112.44M
-
EBIT after Unusual Expense
1.10B 1.24B 750.40M 1.05B
Non Operating Income/Expense
18.24M 120.56M (25.22M) (23.78M)
Non-Operating Interest Income
15.96M 14.18M 30.48M 74.60M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
99.18M 87.47M 111.40M 207.57M
Interest Expense Growth
-11.39% -11.81% +27.37% +86.33%
Gross Interest Expense
99.18M 87.47M 111.40M 207.57M
Interest Capitalized
- - - -
-
Pretax Income
1.02B 1.28B 613.77M 818.40M
Pretax Income Growth
+19.03% +25.14% -51.87% +33.34%
Pretax Margin
+10.48% +11.25% +5.38% +7.10%
Income Tax
274.73M 290.77M 224.91M 320.01M
Income Tax - Current - Domestic
151.62M 199.75M 233.32M 329.74M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
123.12M 91.01M (8.41M) (9.73M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
772.90M 1.02B 407.78M 527.58M
Minority Interest Expense
46.74M 42.55M 27.33M 44.33M
Net Income
726.16M 972.77M 380.45M 483.26M
Net Income Growth
+25.49% +33.96% -60.89% +27.02%
Net Margin Growth
+7.47% +8.58% +3.34% +4.19%
Extraordinaries & Discontinued Operations
(7.98M) 7.09M (10.51M) (5.41M)
Discontinued Operations
(7.98M) 7.09M (10.51M) (5.41M)
Net Income After Extraordinaries
718.18M 979.86M 369.94M 477.85M
Preferred Dividends
- - - -
-
Net Income Available to Common
718.18M 979.86M 369.94M 477.85M
EPS (Basic)
1.2506 1.7659 0.7057 0.9338
EPS (Basic) Growth
+38.16% +41.20% -60.04% +32.32%
Basic Shares Outstanding
574.28M 554.89M 524.21M 511.73M
EPS (Diluted)
1.2462 1.7572 0.7034 0.9296
EPS (Diluted) Growth
+38.16% +41.00% -59.97% +32.16%
Diluted Shares Outstanding
576.31M 557.63M 525.95M 514.02M
EBITDA
1.52B 1.66B 1.22B 1.55B
EBITDA Growth
+12.24% +9.38% -26.11% +26.27%
EBITDA Margin
+15.58% +14.62% +10.74% +13.40%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 26.153
Number of Ratings 18 Current Quarters Estimate 0.276
FY Report Date 12 / 2024 Current Year's Estimate 1.454
Last Quarter’s Earnings 0.409 Median PE on CY Estimate N/A
Year Ago Earnings 1.101 Next Fiscal Year Estimate 1.612
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 2 16 17
Mean Estimate 0.28 0.37 1.45 1.61
High Estimates 0.38 0.41 1.58 1.82
Low Estimate 0.20 0.33 1.25 1.27
Coefficient of Variance 26.65 16.76 5.96 8.25

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 7
OVERWEIGHT 2 2 2
HOLD 6 6 6
UNDERWEIGHT 1 1 2
SELL 1 1 1
MEAN Overweight Overweight Overweight

Akzo Nobel Nv in the News